1. Background
2. Objectives
3. Methods
3.1. Blood Pressure Transmitter Remote Installation Method
3.2. Renal Sympathetic Nerve Activity Recording Method
3.3. Inflammatory Indices Assessments
3.4. Renal Oxidative Stress Assessments
3.5. Measurement of Renal Hydrogen Sulfide Levels
3.6. Statistical Analysis
4. Results
4.1. Effect of PAG on the Beneficial Effects of the Exercise
A, changes in plasma creatinine; and B, BUN in different groups. Data are presented as Mean ± SEM. Chronic kidney disease (CKD), 5/6 Nx; Exe, 5/6 Nx + exercise; PAG, 5/6 Nx + exercise + D L-propargylglycine.* P < 0.05 significance differences with Sham group. # P < 0.05 significance differences with CKD group. & P < 0.05 significance differences with Exe group.
A, changes in renal superoxide dismutase (SOD) activity; B, malondialdehyde (MDA) level and hydrogen sulfide (H2S) level; C, in different groups. Data are presented as Mean ± SEM. Chronic kidney disease (CKD), 5/6 Nx; Exe, 5/6 Nx + exercise; PAG, 5/6 Nx+exercise+D, L-propargylglycine.* P < 0.05 significance differences with Sham group. # P < 0.05 significance differences with CKD group. & P < 0.05 significance differences with Exe group.
A, changes in systolic blood pressure (BP) in the end of 8 weeks; B, SBP monitoring for the last 48 hours; and C, renal sympathetic nerve activity (RSNA) in different groups. Data are presented as Mean ± SEM. Chronic kidney disease (CKD), 5/6 Nx; Exe, 5/6 Nx+exercise; PAG, 5/6 Nx + exercise + D, L-propargylglycine.* P < 0.05 significance differences with Sham group. # P < 0.05 significance differences with CKD group. & P < 0.05 significance differences with Exe group.
A, Changes in renal TNF-α; B, and IL-6 levels in different groups. Data are presented as Mean ± SEM. Chronic kidney disease (CKD), 5/6 Nx; Exe, 5/6 Nx + exercise; PAG, 5/6 Nx + exercise + D; L-propargylglycine.* P < 0.05 significance differences with Sham group. # P < 0.05 significance differences with CKD group. & P < 0.05 significance differences with Exe group.



